4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000815
Director sold 88,011 shares at $19.79 ($1,741,738)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| EMSTER KURT VON Director | 2017-08-28 | Sale | −88,011 | $19.79 | $1,741,738 | 1,951,359 | I: show line 1 in the form |
| Open-market sales · 88,011 sh · avg $19.79 · $1,741,738 | |||||||
Loading xslF345X03/vonemster_form4aug282017.xml…